Register Login

Ionis Pharmaceuticals Inc (IONS)

Baroldi Joseph 🟡 adjusted position in 32.8K shares (3 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $62.01 ($4.0M) Transaction Date: Sep 03, 2025 | Filing ID: 000215

Full text
Register to leave comments
  • News bot Sept. 5, 2025, 12:35 a.m.

    🔍 Baroldi Joseph (Executive)

    Company: IONIS PHARMACEUTICALS INC (IONS)

    Report Date: 2025-09-03

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 3
    • Holdings reported: 1
    • Total shares acquired: 32,800
    • Total shares sold: 65,600
    • Total shares held: 3,071

    Detailed Transactions and Holdings:

    • Acquired 2,800 shares of Common Stock at $31.8 per share (Direct)
      Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 34,726.00 | transaction_form_type: 4
    • Sold 2,800 shares of Common Stock at $62.0101 per share (Direct)
      Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,926.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 15,000 shares of Common Stock at $31.8 per share (Direct)
      Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 46,926.00 | transaction_form_type: 4
    • Sold 30,000 shares of Common Stock at $59.0864 per share (Direct)
      Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,926.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Acquired 15,000 shares of Common Stock at $31.8 per share (Direct)
      Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 31,926.00 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-09-03 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 3,071.00
    • Sold 2,800 shares of Non-Qualified Stock Option (right to buy) at $31.8 per share (Derivative)
      Date: 2025-09-03 | Code: M | Expires: 2032-01-30 | Exercise: 2023-01-31 | equity_swap_involved: 0 | shares_owned_after: 83,900.00 | transaction_form_type: 4
    • Sold 15,000 shares of Non-Qualified Stock Option (right to buy) at $31.8 per share (Derivative)
      Date: 2025-09-03 | Code: M | Expires: 2032-01-30 | Exercise: 2023-01-31 | equity_swap_involved: 0 | shares_owned_after: 68,900.00 | transaction_form_type: 4
    • Sold 15,000 shares of Non-Qualified Stock Option (right to buy) at $31.8 per share (Derivative)
      Date: 2025-09-03 | Code: M | Expires: 2032-01-30 | Exercise: 2023-01-31 | equity_swap_involved: 0 | shares_owned_after: 53,900.00 | transaction_form_type: 4

    Footnotes:

    • F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.59 to $59.26 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.03 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.

Search

News categories